- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Immune checkpoint inhibitor-induced diarrhea and colitis: an overview ; volume:32 ; number:10 ; day:23 ; month:9 ; year:2024 ; pages:1-10 ; date:10.2024
Supportive care in cancer ; 32, Heft 10 (23.9.2024), 1-10, 10.2024
- Urheber
-
Zoghbi, Marianne
Burk, Kathryn J.
Haroun, Elio
Saade, Maria
Carreras, Maria Teresa Cruz
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-024-08889-2
- URN
-
urn:nbn:de:101:1-2501082102031.093826086592
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zoghbi, Marianne
- Burk, Kathryn J.
- Haroun, Elio
- Saade, Maria
- Carreras, Maria Teresa Cruz
- SpringerLink (Online service)
Ähnliche Objekte (12)
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab
Importance of endoscopic and histological evaluation in the management of immune checkpoint inhibitor-induced colitis
Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson
Severe Diarrhea in the Setting of Immune Checkpoint Inhibitors
Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis
Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Budesonide treatment for microscopic colitis from immune checkpoint inhibitors
Correction to: Impact of antibiotic therapy on the development and response to treatment of immune checkpoint inhibitor-mediated diarrhea and colitis
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis
Diffuse Metastatic Melanoma in the GI Lumen Following Immune Checkpoint Inhibitor Colitis Treatment
Severe Inflammatory Colitis Related to Encorafenib and Binimetinib following Immune Checkpoint Inhibitor Therapy
Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis
Acute liver injury in the context of immune checkpoint inhibitor-related colitis treated with infliximab